• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LOXL-2 和 TNC-C 是 HCV/HIV-、HIV- 和 HCV 感染患者肝纤维化的标志物。

LOXL-2 and TNC-C are markers of liver fibrogenesis in HCV/HIV-, HIV- and HCV-infected patients.

机构信息

Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA 02114, USA.

Department of Medicine, University of California San Francisco, School of Medicine, San Francisco, CA 94143, USA.

出版信息

Biomark Med. 2022 Aug;16(11):839-846. doi: 10.2217/bmm-2021-0596. Epub 2022 Jul 5.

DOI:10.2217/bmm-2021-0596
PMID:35786977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9437769/
Abstract

Lysil oxidase like enzyme-2 (LOXL-2) and TNC-C play important roles in organ fibrosis. We assessed circulating LOXL-2 and TNC-C levels and their relationship to fibrosis severity in HIV- and/or HCV-infected individuals. Healthy controls (n = 22), HIV mono- (n = 15), HCV mono- (n = 52) and HCV/HIV-co-infected (n = 92) subjects were included. LOXL-2 and TNC-C levels were significantly higher in HCV mono- and HCV/HIV-co-infected individuals with F0 compared to healthy controls. In addition, in HCV/HIV-co-infected individuals, LOXL-2 levels were higher in intermediate fibrosis compared to no/mild fibrosis. In HCV/HIV-co-infected study participants, both LOXL-2 and TNC-C were significantly higher in intermediate fibrosis compared to no/mild fibrosis, but did not further increase with advanced fibrosis. Furthermore, both markers were elevated among HCV/HIV-positive individuals with mild/no fibrosis.

摘要

赖氨酰氧化酶样酶 2(LOXL-2)和 TNC-C 在器官纤维化中发挥重要作用。我们评估了 HIV-和/或 HCV 感染个体中循环 LOXL-2 和 TNC-C 水平及其与纤维化严重程度的关系。纳入了健康对照组(n=22)、HIV 单感染组(n=15)、HCV 单感染组(n=52)和 HCV/HIV 共感染组(n=92)。与健康对照组相比,HCV 单感染和 HCV/HIV 共感染的 F0 个体中 LOXL-2 和 TNC-C 水平显著升高。此外,在 HCV/HIV 共感染个体中,与无/轻度纤维化相比,中纤维化个体的 LOXL-2 水平更高。在 HCV/HIV 共感染研究参与者中,与无/轻度纤维化相比,中纤维化患者的 LOXL-2 和 TNC-C 均显著升高,但随着纤维化程度的加重,其水平并未进一步升高。此外,轻度/无纤维化的 HCV/HIV 阳性个体中这两种标志物均升高。

相似文献

1
LOXL-2 and TNC-C are markers of liver fibrogenesis in HCV/HIV-, HIV- and HCV-infected patients.LOXL-2 和 TNC-C 是 HCV/HIV-、HIV- 和 HCV 感染患者肝纤维化的标志物。
Biomark Med. 2022 Aug;16(11):839-846. doi: 10.2217/bmm-2021-0596. Epub 2022 Jul 5.
2
Proteomic fingerprinting in HIV/HCV co-infection reveals serum biomarkers for the diagnosis of fibrosis staging.在 HIV/HCV 合并感染中进行蛋白质组指纹图谱分析,揭示了用于纤维化分期诊断的血清生物标志物。
PLoS One. 2018 Apr 2;13(4):e0195148. doi: 10.1371/journal.pone.0195148. eCollection 2018.
3
Mucosal-associated invariant T-cell frequency and function in blood and liver of HCV mono- and HCV/HIV co-infected patients with advanced fibrosis.在伴有晚期纤维化的 HCV 单感染和 HCV/HIV 共感染患者的血液和肝脏中,黏膜相关不变 T 细胞的频率和功能。
Liver Int. 2018 Mar;38(3):458-468. doi: 10.1111/liv.13544. Epub 2017 Sep 16.
4
Predictive value of liver enzymes and inflammatory biomarkers for the severity of liver fibrosis stage in HIV/HCV co-infected patients.肝酶和炎症生物标志物对 HIV/HCV 合并感染患者肝纤维化严重程度的预测价值。
PLoS One. 2013;8(3):e59205. doi: 10.1371/journal.pone.0059205. Epub 2013 Mar 19.
5
The Association of PNPLA3, COX-2 and DHCR7 Polymorphisms with Advanced Liver Fibrosis in Patients with HCV Mono- Infection and HCV/HIV Co-Infection.PNPLA3、COX-2和DHCR7基因多态性与丙型肝炎病毒(HCV)单一感染及HCV/人类免疫缺陷病毒(HIV)合并感染患者肝纤维化进展的相关性
Asian Pac J Cancer Prev. 2018 Aug 24;19(8):2191-2197. doi: 10.22034/APJCP.2018.19.8.2191.
6
Advanced liver fibrosis by transient elastography, fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: role of vitamin D levels.在合并和未合并人类免疫缺陷病毒感染的亚洲丙型肝炎患者中,通过瞬时弹性成像、纤维化4以及丙氨酸氨基转移酶/血小板比值指数评估的晚期肝纤维化:维生素D水平的作用
J Gastroenterol Hepatol. 2014 Sep;29(9):1706-14. doi: 10.1111/jgh.12613.
7
HCV co-infection and markers of liver injury and fibrosis among HIV-positive childbearing women in Ukraine: results from a cohort study.乌克兰HIV阳性育龄妇女中的丙型肝炎病毒合并感染以及肝损伤和纤维化标志物:一项队列研究的结果
BMC Infect Dis. 2016 Dec 12;16(1):755. doi: 10.1186/s12879-016-2089-7.
8
Suboptimal performance of APRI and FIB-4 in ruling out significant fibrosis and confirming cirrhosis in HIV/HCV co-infected and HCV mono-infected patients.APRI 和 FIB-4 在排除 HIV/HCV 合并感染和 HCV 单感染患者的显著纤维化和确认肝硬化方面表现不佳。
Infection. 2019 Jun;47(3):409-415. doi: 10.1007/s15010-018-1258-6. Epub 2018 Dec 5.
9
Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index.HIV-丙型肝炎病毒合并感染中的肝纤维化进展——性别对通过天冬氨酸与血小板比值指数测量的显著纤维化风险的影响。
PLoS One. 2015 Jun 19;10(6):e0129868. doi: 10.1371/journal.pone.0129868. eCollection 2015.
10
Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection.HIV感染、HCV感染及HIV/HCV合并感染中的肝纤维化、微生物易位和免疫激活标志物
Dig Liver Dis. 2015 Mar;47(3):218-25. doi: 10.1016/j.dld.2014.11.012. Epub 2014 Nov 29.

引用本文的文献

1
A virological view of tenascin-C in infection.从病毒学角度看 tenascin-C 在感染中的作用。
Am J Physiol Cell Physiol. 2023 Jan 1;324(1):C1-C9. doi: 10.1152/ajpcell.00333.2022. Epub 2022 Dec 2.

本文引用的文献

1
Insights Into the Pathophysiology of Liver Disease in HCV/HIV: Does it End With HCV Cure?丙型肝炎/艾滋病患者肝脏疾病的病理生理学见解:丙型肝炎治愈了,一切就结束了吗?
J Infect Dis. 2020 Nov 27;222(Suppl 9):S802-S813. doi: 10.1093/infdis/jiaa279.
2
LOXL2 Inhibition Paves the Way for Macrophage-Mediated Collagen Degradation in Liver Fibrosis.LOXL2 抑制为巨噬细胞介导的肝纤维化胶原降解铺平道路。
Front Immunol. 2020 Mar 31;11:480. doi: 10.3389/fimmu.2020.00480. eCollection 2020.
3
Lysyl Oxidase (LOX) Family Members: Rationale and Their Potential as Therapeutic Targets for Liver Fibrosis.赖氨酰氧化酶(LOX)家族成员:原理及其作为肝纤维化治疗靶点的潜力。
Hepatology. 2020 Aug;72(2):729-741. doi: 10.1002/hep.31236.
4
Collagen biology and non-invasive biomarkers of liver fibrosis.胶原蛋白生物学与肝纤维化的非侵入性生物标志物
Liver Int. 2020 Apr;40(4):736-750. doi: 10.1111/liv.14390. Epub 2020 Feb 19.
5
Serum markers of type III and IV procollagen processing predict recurrence of fibrosis in liver transplanted patients.血清 III 型和 IV 型前胶原处理标志物可预测肝移植患者纤维化复发。
Sci Rep. 2019 Oct 16;9(1):14857. doi: 10.1038/s41598-019-51394-4.
6
Changes in Circulating Lysyl Oxidase-Like-2 (LOXL2) Levels, HOMA, and Fibrosis after Sustained Virological Response by Direct Antiviral Therapy.直接抗病毒治疗实现持续病毒学应答后循环赖氨酰氧化酶样蛋白2(LOXL2)水平、胰岛素抵抗稳态模型评估(HOMA)及纤维化的变化
J Clin Med. 2019 Aug 17;8(8):1242. doi: 10.3390/jcm8081242.
7
Tenascin-C accelerates adverse ventricular remodelling after myocardial infarction by modulating macrophage polarization.Tenascin-C 通过调节巨噬细胞极化加速心肌梗死后的不良心室重构。
Cardiovasc Res. 2019 Mar 1;115(3):614-624. doi: 10.1093/cvr/cvy244.
8
Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease.西姆土单抗治疗原发性硬化性胆管炎:2 期研究结果及对疾病自然史的见解。
Hepatology. 2019 Feb;69(2):684-698. doi: 10.1002/hep.30237. Epub 2019 Jan 11.
9
Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis.西妥昔单抗对非酒精性脂肪性肝炎引起的桥接纤维化或代偿性肝硬化患者无效。
Gastroenterology. 2018 Oct;155(4):1140-1153. doi: 10.1053/j.gastro.2018.07.006. Epub 2018 Jul 7.
10
Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection.巨噬细胞活化标志物可溶性 CD163 是人类免疫缺陷病毒/丙型肝炎病毒合并感染中肝纤维化的动态标志物。
J Infect Dis. 2018 Sep 22;218(9):1394-1403. doi: 10.1093/infdis/jiy331.